ID: ALA337591

Max Phase: Preclinical

Molecular Formula: C17H20N2O2

Molecular Weight: 284.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(CC1CC2CCC(C1)N2)c1c[nH]c2cc(O)ccc12

Standard InChI:  InChI=1S/C17H20N2O2/c20-13-3-4-14-15(9-18-16(14)8-13)17(21)7-10-5-11-1-2-12(6-10)19-11/h3-4,8-12,18-20H,1-2,5-7H2

Standard InChI Key:  IEUXRHDPSSNADT-UHFFFAOYSA-N

Associated Targets(Human)

Serotonin 3 (5-HT3) receptor 617 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 284.36Molecular Weight (Monoisotopic): 284.1525AlogP: 2.98#Rotatable Bonds: 3
Polar Surface Area: 65.12Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.51CX Basic pKa: 11.25CX LogP: 0.95CX LogD: -0.76
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.76Np Likeness Score: 0.75

References

1. Blum E, Buchheit K, Buescher H, Gamse R, Kloeppner E, Meigel H, Papageorgiou C, Waelchli R, Revesz L.  (1992)  Design and synthesis of novel ligands for the 5-HT3 and the 5-HT4 receptor,  (5): [10.1016/S0960-894X(00)80170-5]

Source